does tirzepatide cause extreme fatigue Make You Tired? Tirzepatide Injections for Medical Weight

Tirzepatide is a dual GIP/GLP-1 receptor agonist, a peptide that works on two key incretin pathways in the body to regulate blood sugar, reduce appetite, and promote meaningful weight loss

By targeting these two distinct hunger pathways, Tirzepatide effectively regulates appetite, slows gastric emptying, and improves how your body metabolizes sugar

A post hoc analysis of the phase IIb trial showed that tirzepatide was associated with a reduction in the level of high-sensitivity ICAM-1, CRP, and YKL-40 after 26 weeks of treatment in a dose-dependent manner [83, 103]

Adverse Events In both phase 2 trials, there were no major safety signals with retatrutide use [45, 46]

SURMOUNT Trials in Obesity Management The SURMOUNT program extended tirzepatide evaluation to obesity treatment in patients without diabetes

GLP-1 receptor agonist NLY01 reduces retinal inflammation and neuron death secondary to ocular hypertension